Andreas Regnery

As a co-founder of Belyntic, he served as the managing director, spearheading financial matters, fundraising, business plan development, and HR initiatives. His leadership resulted in the successful fundraising of approximately €3 million and earned Belyntic several prestigious awards. Notably, he played a key role in overseeing the acquisition of Belyntic’s patent portfolios related to their innovative peptide manufacturing technology by Mesa Laboratories Inc. (NASDAQ: MLAB) in late 2022.

He ardently pursues advancing peptide manufacturing knowledge into the development of groundbreaking drugs, and he remains committed to his role as managing director at Belyntic, driving forward the journey of innovation.

Andreas earned a master’s degree in finance and economics, along with a minor degree in electrical engineering, from the University of Kaiserslautern. Before joining Belyntic, he accumulated over three years of experience in strategic management consulting.